GSK halts new clinical trials in Russia but continues supply of medicines

Belfast Telegraph

17 Mar 2022 0 shares 1 views

Belfast Telegraph

Published 17 Mar 2022

GlaxoSmithKline (GSK) has said it will keep supplying essential medicines in Russia but will halt new clinical trials due to the invasion of Ukraine.

Full Article

Medicine market in Russia ‘stable’ as GSK commits to keeping up supply

GlaxoSmithKline’s (GSK) will halt clinical trials in Russia but maintain the supply of essential medicines, following the..

City A.M. 17 Mar 2022